Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FSB38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,003
Award facts
- Contract value 100% obligated
- $10,002.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Cosentyx (secukinumab) 300 mg pens, 2 mL formulation, valued at $10,002.67. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The delivery order supports the Defense Logistics Agency's Medical Supply Chain mission to provide pharmaceutical products to military and federal healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor, maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. Cosentyx is a specialty immunosuppressant medication used for the treatment of autoimmune conditions. This transaction exemplifies the company's role as a critical vendor for federal medical procurement, fulfilling specific pharmaceutical requirements for military healthcare programs through the DLA's global pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DB25FSB38?
SPE2DB25FSB38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FSB38 worth?
The government has obligated $10,003 on SPE2DB25FSB38.
Is contract SPE2DB25FSB38 an order under another contract?
Yes. SPE2DB25FSB38 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FSB38 competed?
The extent of competition for SPE2DB25FSB38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award